Suboptimal rates of cervical testing among women with inflammatory bowel disease.

ABSTRACT:

Background & aims

Women with IBD have a high incidence of abnormal cervical cytology. However, little is known about how frequently women with IBD are tested for cervical abnormalities. We aimed to determine cervical testing rates among women with IBD, specifically those on immunosuppressant medications, and to identify risk factors associated with low incidence of screening.

Methods

With the PharMetrics Patient-Centric Database from 1996-2005, we identified cases of IBD and matched controls via a validated algorithm. With logistic regression, we compared utilization of cervical testing with IBD case status, patients' age, use of immunosuppressive medications, Medicaid insurance status, and use of primary care services.

Results

Only 70.4% of women with IBD (n = 9356)

SUBMITTER: Long MD 

PROVIDER: S-EPMC2838487 | biostudies-literature | 2009 May

REPOSITORIES: biostudies-literature